# GRIA1

## Overview
The GRIA1 gene encodes the glutamate ionotropic receptor AMPA type subunit 1, commonly referred to as GluA1, which is a critical component of AMPA receptors. These receptors are integral membrane proteins that function as ion channels, mediating fast excitatory synaptic transmission in the central nervous system. The GluA1 subunit plays a pivotal role in synaptic plasticity, learning, and memory by facilitating the flow of sodium and calcium ions into neurons. The GRIA1 gene undergoes alternative splicing, resulting in various isoforms that contribute to the functional diversity of AMPA receptors. Dysregulation of GRIA1 has been implicated in several neurological disorders, including schizophrenia and migraine, highlighting its importance in maintaining normal cognitive and neurological functions (Azim2011Alternatively; Kang2012Genetic; Magri2006Glutamate).

## Structure
The GRIA1 gene encodes the GluA1 subunit of AMPA receptors, which are crucial for fast excitatory synaptic transmission in the brain. The primary structure of the GluA1 subunit consists of a sequence of amino acids that form the protein. The secondary structure includes alpha helices and beta sheets, which contribute to the protein's stability and function. The tertiary structure involves the folding of these elements into a three-dimensional shape, forming ligand-binding and transmembrane domains. The quaternary structure of the GluA1 subunit is a tetrameric assembly with other subunits, which is essential for the receptor's function as an ion channel (Azim2011Alternatively).

Post-translational modifications, such as phosphorylation, play a significant role in regulating the function of the GluA1 subunit. These modifications can influence receptor assembly, targeting, and modulation, affecting synaptic plasticity and transmission (Azim2011Alternatively). The GRIA1 gene undergoes alternative splicing, resulting in different isoforms, including the well-known flip and flop variants, which differ in their channel kinetics and pharmacological properties (Azim2011Alternatively). These splice variants contribute to the functional diversity of AMPA receptors, allowing for various subunit combinations and receptor properties.

## Function
The GRIA1 gene encodes the GluA1 subunit of AMPA-type glutamate receptors, which are crucial for fast excitatory synaptic transmission in the central nervous system. These receptors are primarily active at postsynaptic sites in neurons, where they mediate the flow of sodium and calcium ions into the cell, influencing synaptic plasticity, learning, and memory (Asthana2022Cerebellar; Kang2012Genetic). 

In healthy human cells, GluA1-containing AMPA receptors are essential for synaptic function and are involved in processes such as spatial short-term memory and attentional regulation (Kilonzo2022Distinct). These receptors play a significant role in hippocampal synaptic long-term potentiation (LTP) and depression (LTD), which are critical for memory formation and retention (Crisafulli2012Influence). 

The synaptic delivery of GluA1-containing receptors is regulated by specific molecular mechanisms, such as long-term potentiation or calcium/calmodulin-dependent protein kinase II (CaMKII) activity, which drive these receptors into synapses (Shi2001SubunitSpecific). The proper functioning of these receptors is vital for efficient information processing at glutamate synapses, necessary for normal cognitive and neurological functions (Kang2012Genetic).

## Clinical Significance
Mutations and alterations in the GRIA1 gene, which encodes the GluA1 subunit of AMPA receptors, have been implicated in several neurological disorders. The GRIA1 gene is associated with schizophrenia, as studies have shown significant differences in allele frequencies of specific single nucleotide polymorphisms (SNPs) between schizophrenia patients and controls. These findings suggest that certain polymorphisms in GRIA1 may increase susceptibility to schizophrenia, potentially due to glutamatergic dysfunction (Magri2006Glutamate).

In addition to schizophrenia, GRIA1 variants have been linked to migraine. A case-control study identified a significant association between the rs2195450 SNP in GRIA1 and migraine, with an overrepresentation of the T allele in migraine patients. This suggests that alterations in GRIA1 may contribute to migraine pathophysiology, particularly in subtypes with and without aura (Fang2015Casecontrol).

Overall, the GRIA1 gene plays a critical role in the pathogenesis of these disorders, likely through its involvement in synaptic plasticity and neurotransmission. Dysregulation of GRIA1 expression or function can lead to altered synaptic processes, contributing to the clinical manifestations observed in these conditions.

## Interactions
GRIA1, a subunit of AMPA receptors, is involved in several protein interactions crucial for synaptic transmission and plasticity. It interacts with transmembrane AMPA receptor regulatory proteins (TARPs), which are essential for receptor trafficking and modulation. These interactions are critical for the synaptic delivery of AMPA receptors, as TARPs influence the gating and pharmacology of the receptors (Lu2010Synaptic).

The phosphorylation of GRIA1 at the S567 site by CaMKII is a key regulatory mechanism that affects its interaction with other proteins. This phosphorylation event negatively regulates the synaptic trafficking of AMPA receptors, highlighting the importance of post-translational modifications in GRIA1's interactions (Lu2010Synaptic).

GRIA1 is also part of a broader synaptic interactome, as indicated by its inclusion in the p140Cap protein network. This network is associated with synaptic functions and psychiatric disorders, suggesting that GRIA1's interactions extend to various synaptic proteins involved in complex signaling pathways (Alfieri2017Synaptic). However, specific physical interactions of GRIA1 with other proteins or nucleic acids are not detailed in the provided context.


## References


[1. (Crisafulli2012Influence) Concetta Crisafulli, Alberto Chiesa, Diana De Ronchi, Changsu Han, Soo-Jung Lee, Moon Ho Park, Ashwin A. Patkar, Chi-Un Pae, and Alessandro Serretti. Influence of gria1, gria2 and gria4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia. Neuroscience Letters, 506(1):170–174, January 2012. URL: http://dx.doi.org/10.1016/j.neulet.2011.10.074, doi:10.1016/j.neulet.2011.10.074. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.neulet.2011.10.074)

[2. (Shi2001SubunitSpecific) Song-Hai Shi, Yasunori Hayashi, José A. Esteban, and Roberto Malinow. Subunit-specific rules governing ampa receptor trafficking to synapses in hippocampal pyramidal neurons. Cell, 105(3):331–343, May 2001. URL: http://dx.doi.org/10.1016/s0092-8674(01)00321-x, doi:10.1016/s0092-8674(01)00321-x. This article has 882 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0092-8674(01)00321-x)

[3. (Magri2006Glutamate) Chiara Magri, Rita Gardella, Stefano Davide Barlati, Damiano Podavini, Paraskevas Iatropoulos, Silvia Bonomi, Paolo Valsecchi, Emilio Sacchetti, and Sergio Barlati. Glutamate ampa receptor subunit 1 gene (gria1) and dsm‐iv‐tr schizophrenia: a pilot case‐control association study in an italian sample. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141B(3):287–293, March 2006. URL: http://dx.doi.org/10.1002/ajmg.b.30294, doi:10.1002/ajmg.b.30294. This article has 35 citations.](https://doi.org/10.1002/ajmg.b.30294)

[4. (Asthana2022Cerebellar) Pallavi Asthana, Gajendra Kumar, Lukasz M. Milanowski, Ngan Pan Bennett Au, Siu Chung Chan, Jianpan Huang, Hemin Feng, Kin Ming Kwan, Jufang He, Kannie Wai Yan Chan, Zbigniew K. Wszolek, and Chi Him Eddie Ma. Cerebellar glutamatergic system impacts spontaneous motor recovery by regulating gria1 expression. npj Regenerative Medicine, September 2022. URL: http://dx.doi.org/10.1038/s41536-022-00243-6, doi:10.1038/s41536-022-00243-6. This article has 5 citations.](https://doi.org/10.1038/s41536-022-00243-6)

[5. (Kang2012Genetic) Won Sub Kang, Jin Kyung Park, Su Kang Kim, Hae Jeong Park, Sang Min Lee, Ji Young Song, Joo-Ho Chung, and Jong Woo Kim. Genetic variants of gria1 are associated with susceptibility to schizophrenia in korean population. Molecular Biology Reports, 39(12):10697–10703, October 2012. URL: http://dx.doi.org/10.1007/s11033-012-1960-x, doi:10.1007/s11033-012-1960-x. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11033-012-1960-x)

[6. (Lu2010Synaptic) Wei Lu, Kaname Isozaki, Katherine W. Roche, and Roger A. Nicoll. Synaptic targeting of ampa receptors is regulated by a camkii site in the first intracellular loop of glua1. Proceedings of the National Academy of Sciences, 107(51):22266–22271, December 2010. URL: http://dx.doi.org/10.1073/pnas.1016289107, doi:10.1073/pnas.1016289107. This article has 71 citations.](https://doi.org/10.1073/pnas.1016289107)

[7. (Fang2015Casecontrol) Jie Fang, Xingkai An, Shuai Chen, Zhenzhen Yu, Qilin Ma, and Hongli Qu. Case-control study of gria1 and gria3 gene variants in migraine. The Journal of Headache and Pain, December 2015. URL: http://dx.doi.org/10.1186/s10194-016-0592-2, doi:10.1186/s10194-016-0592-2. This article has 18 citations.](https://doi.org/10.1186/s10194-016-0592-2)

[8. (Kilonzo2022Distinct) Kasyoka Kilonzo, Daniel Strahnen, Vivien Prex, John Gems, Bastiaan van der Veen, Sampath K. T. Kapanaiah, Bhargavi K. B. Murthy, Stefanie Schulz, Rolf Sprengel, David Bannerman, and Dennis Kätzel. Distinct contributions of glua1-containing ampa receptors of different hippocampal subfields to salience processing, memory and impulse control. Translational Psychiatry, March 2022. URL: http://dx.doi.org/10.1038/s41398-022-01863-8, doi:10.1038/s41398-022-01863-8. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41398-022-01863-8)

[9. (Azim2011Alternatively) Shafquat Azim, Abdul Rouf Banday, and Mohammad Tabish. Alternatively spliced three novel transcripts of gria1 in the cerebellum and cortex of mouse brain. Neurochemical Research, 37(1):193–201, September 2011. URL: http://dx.doi.org/10.1007/s11064-011-0599-7, doi:10.1007/s11064-011-0599-7. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11064-011-0599-7)

[10. (Alfieri2017Synaptic) Annalisa Alfieri, Oksana Sorokina, Annie Adrait, Costanza Angelini, Isabella Russo, Alessandro Morellato, Michela Matteoli, Elisabetta Menna, Elisabetta Boeri Erba, Colin McLean, J. Douglas Armstrong, Ugo Ala, Joseph D. Buxbaum, Alfredo Brusco, Yohann Couté, Silvia De Rubeis, Emilia Turco, and Paola Defilippi. Synaptic interactome mining reveals p140cap as a new hub for psd proteins involved in psychiatric and neurological disorders. Frontiers in Molecular Neuroscience, June 2017. URL: http://dx.doi.org/10.3389/fnmol.2017.00212, doi:10.3389/fnmol.2017.00212. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2017.00212)